Quest Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$853K Sell
30,395
-892
-3% -$23.7K 0.1% 83
2025
Q4
$779K Sell
31,287
-481
-2% -$12.1K 0.08% 86
2025
Q3
$809K Buy
31,768
+405
+1% +$10K 0.09% 88
2025
Q2
$760K Buy
+31,363
New +$731K 0.08% 88

Other funds holding PFE

Quest Investment Management's PFE Position: Q1 2026 in Review

Quest Investment Management reduced its Pfizer (PFE) stake by 2.9% in Q1 2026, selling an estimated $23.7K and leaving 30,395 shares worth $853K. The position accounts for 0.1% of the portfolio, ranked #83.

Quest Investment Management first reported a position in PFE in Q2 2025 and has held it in 4 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Quest Investment Management held 30,395 shares of Pfizer worth $853K as of Q1 2026.
  • Quest Investment Management sold 892 Pfizer shares in Q1 2026, an estimated $23.7K.
  • Pfizer made up 0.1% of Quest Investment Management's portfolio in Q1 2026, its #83 holding.
  • Quest Investment Management first reported a position in Pfizer in Q2 2025 and has held it in 4 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Quest Investment Management's 13F filing for Q1 2026, filed 15 May 2026.